TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Indutrade Life Science AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
434
|
236
|
247 |
Financial expenses |
27
|
2
|
0 |
Earnings before taxes |
-3,018
|
-2,052
|
-1,752 |
EBITDA |
-2,996
|
-2,051
|
-1,752 |
Total assets |
3,341
|
2,262
|
1,894 |
Current assets |
3,341
|
2,262
|
1,894 |
Current liabilities |
2,226
|
1,136
|
626 |
Equity capital |
1,116
|
1,126
|
1,269 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
6
![]() |
6
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.4%
|
49.8%
|
67.0% |
Turnover per employee |
72
|
39
|
62 |
Profit as a percentage of turnover |
-695.4%
|
-869.5%
|
-709.3% |
Return on assets (ROA) |
-89.5%
|
-90.6%
|
-92.5% |
Current ratio |
150.1%
|
199.1%
|
302.6% |
Return on equity (ROE) |
-270.4%
|
-182.2%
|
-138.1% |
Change turnover |
197
|
9
|
170 |
Change turnover % |
83%
|
4%
|
223% |
Chg. No. of employees |
0
|
2
|
0 |
Chg. No. of employees % |
0%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.